Effect of depression on stroke morbidity and mortality

Canadian Journal of Psychiatry

Volumn 48, Issue 4, 2003, Pages 250-257

  Ramasubbu, Rajamannar ^a,c   Patten, Scott B ^b  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c FOOTHILLS HOSPITAL   (Canada)

Author keywords

Depression; Stroke morbidity and mortality; Vascular risk factors

Indexed keywords

ADULT; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; COMORBIDITY; DEPRESSION; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PROSPECTIVE STUDY; REVIEW; RISK ASSESSMENT; RISK FACTOR; STROKE; SURVIVAL;

EID: 0038746804     PISSN: 07067437     EISSN: None     Source Type: Journal    
DOI: 10.1177/070674370304800409     Document Type: Review

References (42)

1. Musselman DL, Evans DL, Nemeroff CB. The relationship of depression to cardiovascular disease: epidemiology, biology and treatment. Arch Gen Psychiatry 1998;55:580-92.
2. Glassman AH, Shapiro PA. Depression and the course of coronary artery disease. Am J Psychiatry 1998;155:4-11.
3. Colantonio A, Kasl SV, Ostfeld AM. Depressive symptoms and other psychosocial factors as predictors of stroke in the elderly. Am J Epidemiol 1992;136:884-94.
4. Simonsick EM, Wallace RB, Blazer DG, Berkman LF. Depressive symptomatology and hypertension associated morbidity and mortality in older adults. Psychosom Med 1995;57:427-35.
5. Wassertheil-Smoller S, Applegate WB, Berge K, Chang CJ, Davis BR, Grimm R Jr, and others. Change in depression as a precursor of cardiovascular events. Arch Intern Med 1996;156:553-61.
6. Jonas BS, Mussolino ME. Symptoms of depression as a prospective risk factor for stroke. Psychosom Med 2000;62:463-71.
7. Ohira T, Iso H, Satoh S, Sankai T, Tanigawa T, Ogawa Y, and others. Prospective study of depressive symptoms and risk of stroke among Japanese. Stroke 2001;32:903-8.
8. Larson SL, Owens PL, Ford D, Eaton W. Depressive disorder, dysthymia, and risk of stroke- Thirteen-year follow-up from the Baltimore epidemiologic catchment area study. Stroke 2001;32:1979-83.
9. Simons LA, McCallum J, Friedlander Y, Simons J. Risk factors for ischemic stroke: Dubbo Study of the Elderly. Stroke 1998;29:1341-6.
10. Everson SA, Roberts RE, Goldberg DE, Kaplan GA. Depressive symptoms and increased risk of stroke mortality over a 29-year period. Arch Intern Med 1998;158:1133-8.
11. Wulsin LR, Vaillant GE, Wells VE. A systematic review of the mortality of depression. Psychosom Med 1999;61:6-17.
12. Morris PL, Robinson RG, Andrzejewski P, Samuels J, Price TR. Association of depression with 10-year poststroke mortality. Am J Psychiatry 1993;150:124-9.
13. Morris PL, Robinson RG, Samuels J. Depression, introversion and mortality following stroke. Aust N Z J Psychiatry 1993;27:443-9.
14. Astrom M, Adolfsson R, Asplund K. Major depression in stroke patients: a 3-year longitudinal study. Stroke. 1993;24:976-82.
15. Burvill PW, Johnson GA, Jamrozik KD, Anderson CS, Stewart-Wynne EG, Chakera TMH. Prevalence of depression after stroke: the Perth community stroke study. Br J Psychiatry 1995;166:320-7.
16. House A, Knapp P, Bamford J, Vail A. Mortality at 12 and 24 months after stroke may be associated with depressive symptoms at 1 month. Stroke 2000;32:696-701.
17. Robinson RG. Effect of depression on mortality following stroke. In: Robinson RG, editor. The clinical neuropsychiatry of stroke. Cambridge (UK): Cambridge University Press; 1998. p 226-35.
18. Alexopoulos GS, Meyers BS, Young RC, Kakuma T, Campbell S, Silbersweig D, and others. Vascular depression hypothesis. Arch Gen Psychiatry 1997;54:915-22.
19. National Center for Health Statistics. Health United States; 1994. Dept. of Health and Human Services publication (PH5) 95-1232. Hyattsville (MD): US Public Health Service; 1995.
20. Lenze E, Cross D, McKeel D, Neuman RJ, Sheline YI. White matter hyperintensities and gray matter lesions in physically healthy depressed subjects. Am J Psychiatry 1999;156:1602-7.
21. Kniest A, Reis S, Henning O, Braus D, Deuschle M, Heuser I. Impaired cerebrovascular reactivity in elderly depressed patients. Biol Psychiatry 2001;49:153S. abstract.
22. Fechner-Bates S, Coyne JC, Schwenk TL. The relationship of self reported distress to depressive disorders and other psychopathology. J Consult Clin Psychol 1994;62:550-9.
23. Parikh RM, Eden DT, Price TR, Robinson RG. The sensitivity and specificity of the Centre for Epidemiologic Studies Depression Scale in screening for post stroke depression. Int J Psychiatry Med 1988;18:169-81.
24. Fazio AF. A concurrent validational study of the NCHS General Well-Being Schedule Vital Health Stat II 1997;73:1-53.
25. Roberts RE, Kaplan GA, Camacho TC. Psychological distress and mortality: evidence from the Alameda County Study. Soc Sci Med 1990;31:527-36.
26. Gledhill JT. Cognitive impairment with chronic disease in depression and mortality. Arch Gen Psychiatry 2001;58:306-7.
27. Witteman JC, D'Agostino RB, Stijnen T, Kannel WB, Cobb JC, deRidder MA, and others. G-estimation of causal effects: isolated systolic hypertension and cardiovascular death in the Framingham Heart Study. Am J Epidemiol 1998:148;390-401.
28. Frasure-Smith N, Lesperance F, Talajic M. Depression and 18 month prognosis after myocardial infarction. Circulation 1995;91:999-1005.
29. Musselman DL, Tomer A, Manatunga AK, Knight BT, Porter MR, Kasey S, and others. Exaggerated platelet reactivity in major depression. Am J Psychiatry 1996;153:1313-7.
30. Carney RM, Saunders RD, Freedland KE, Stein P, Rich MW, Jaffe AS. Association of depression with reduced heart rate variability in coronary artery disease. Am J Cardiol 1995;76:562-4.
31. Okamura F, Tashiro A, Utsumi A, Imai T, Suchi T, Tamura D, and others. Insulin resistance in patients with depression and its changes during the clinical course of depression: minimal model analysis. Metabolism 2000;49:125-60.
32. Plotsky PM, Owens MJ, Nemeroff CB. Psychoneuroendocrinology of depression. Hypothalamic pituitary adrenal axis. Psychiatr Clin North Am 1998;21:293-307.
33. Wyatt RJ, Portnoy B, Kupfer DJ, Snyder F, Engelman K. Resting plasma catecholamine concentrations in patients with depression and anxiety. Arch Gen Psychiatry 1971;24:65-70.
34. Maes M. Evidence for an immune response in major depression: a review and hypothesis. Prog Neuropsychopharmacol Biol Psychiatry 1995;19:11-38.
35. Kraemer HC, Kazdin AE, Offord DR, Kessler RC, Jensen PS, Kupfer DJ. Coming to terms with the terms of risk. Arch Gen Psychiatry 1997;54:337-43.
36. Robins JM, Greenland S. Identifiability and exchangeability for direct and indirect effects. Epidemiology 1992:3;143-55.
37. Eaton WW, Armenian H, Gallo J, Pratt L, Ford DE. Depression and risk for onset of type II diabetes. A prospective population-based study. Diabetes Care 1996;19:1097-102.
38. Jonas BS, Frank P, Ingram DD. Are symptoms of anxiety and depression risk factors for hypertension? Longitudinal evidence from the National Health and Nutrition Examination Survey I: epidemiologic follow-up study. Arch Fam Med 1997;6:43-9.
39. Covey LS, Glassman AH, Stetner F. Cigarette smoking and major depression. J Addict Dis 1998;17:35-46.
40. Carpenter KM, Hasin DS, Allison DB, Faith MS. Relationships between obesity and DSM-IV major depressive disorder, suicidal ideation, and suicide attempts: results from a general population study. Am J Public Health. 2000;90:251-7.
41. Everson SA, Kaplan GA, Goldberg DE, Salonen R, Salonen JT. Hopelessness and 4-year progression of carotid atherosclerosis: the Kuopio Ischemic Heart Disease Risk Factor Study. Arterioscler Thromb Vasc Biol 1997;17:1490-5.
42. Ramasubbu R. Relationship between depression and cerebrovascular disease: conceptual issues. J Affect Disord 2000;57:1-11.